<DOC>
	<DOCNO>NCT02744482</DOCNO>
	<brief_summary>This experimental study , prospective , comparative . This clinical trial randomize double-blind , Residronate versus placebo . The study aim demonstrate effectiveness risedronate pain management , 18 month traitment , patient undergo aseptic joint prosthesis loosening . 2 group compare 1 : 1 ratio . The first group receive active drug ( risedronate 75mg ) second placebo . Patients treat 18 month : 1 tablet residronate/placebo per o two consecutive day month . Evaluations plan evry 6 month .</brief_summary>
	<brief_title>Efficacy Risedronate Patients With Painful Periprosthetic Resorption Hip Prothesis</brief_title>
	<detailed_description />
	<mesh_term>Prosthesis Failure</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Male female subject , 18 year age old . Written inform consent Subjects cement cemented total hip prothesis ( primitive secondary coxarthrosis ) Painful aseptic loosening Subject pain 4 great 10 point Visual Pain Rating scale For subject woman reproductive age , must use reliable method ( ) contraception and/or abstinence , duration therapeutic product exposure . Subjects septic loosen hip prosthesis . Subjects bilateral disease Subjects implant mobility associate preoperative intraoperative loosening Subjects antiosteoporotic treatment Subjects stop biphosphonate traetment le one year Subjects know allergy sensitivity component study medication . Subjects Hypocalcemia Females pregnant , breastfeeding , plan pregnancy study think may pregnant start study , female childbearing potential unable unwilling use reliable form contraception study . Subjects severe kidney failure ( creatinine &lt; 30 ml/min ) ) . Subjects participation another research study Subjects previous osteonecrosis jaw</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>